PINEDO HERBERT MD PHD 4

Accession 0001127602-10-016674

CIK 0000729922other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 8:12 PM ET

Size

20.3 KB

Accession

0001127602-10-016674

Form 4

Period: 2010-06-03

Director

Transactions

Disposition to Issuer
Common Stock
2010-06-03$57.50/sh−4,375$251,563→ 6,092 total
Disposition to Issuer
Stock Option (Right to Buy)
2010-06-03$57.50/sh−3,000$172,500→ 0 total
Exercise: $30.39Exp: 2013-06-13→ Common Stock (3,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2010-06-03$57.50/sh−7,500$431,250→ 0 total
Exercise: $38.63Exp: 2015-06-10→ Common Stock (7,500 underlying)
Disposition to Issuer
Common Stock
2010-06-03$57.50/sh−750$43,125→ 5,342 total
Disposition to Issuer
Stock Option (Right to Buy)
2010-06-03$57.50/sh−50,000$2,875,000→ 0 total
Exercise: $82.88Exp: 2014-06-24→ Common Stock (50,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2010-06-03$57.50/sh−7,500$431,250→ 0 total
Exercise: $45.60Exp: 2015-03-15→ Common Stock (7,500 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2010-06-03$57.50/sh−7,500$431,250→ 0 total
Exercise: $28.65Exp: 2016-06-16→ Common Stock (7,500 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2010-06-03$57.50/sh−3,000$172,500→ 0 total
Exercise: $36.25Exp: 2014-06-12→ Common Stock (3,000 underlying)

Footnotes (4)

[F1]Represents the number of unvested Restricted Stock Units that were canceled in exchange for a cash payment of $57.50 per unit in accordance with the Agreement and Plan of Merger, dated as of May 16, 2010, among OSI Pharmaceuticals, Inc., Astellas Pharma Inc., Astellas US Holding, Inc. and Ruby Acquisition, Inc.
[F2]Represents the number of Deferred Stock Units that were canceled in exchange for a cash payment of $57.50 per unit in accordance with the Agreement and Plan of Merger, dated as of May 16, 2010, among OSI Pharmaceuticals, Inc., Astellas Pharma Inc., Astellas US Holding, Inc. and Ruby Acquisition, Inc.
[F3]These stock options were canceled in accordance with the Agreement and Plan of Merger, dated as of May 16, 2010, among OSI Pharmaceuticals, Inc., Astellas Pharma Inc., Astellas US Holding, Inc. and Ruby Acquisition, Inc. As the exercise price of the options was above $57.50, no cash payment was provided.
[F4]These stock options were canceled in exchange for a cash payment in accordance with the Agreement and Plan of Merger, dated as of May 16, 2010, among OSI Pharmaceuticals, Inc., Astellas Pharma Inc., Astellas US Holding, Inc. and Ruby Acquisition, Inc. The cash payment made with respect to each stock option equals the product of (x) the number of shares issuable upon the exercise of such option multiplied by (y) the excess, if any, of $57.50 over the exercise price per share for such option.

Documents

1 file

OSI PHARMACEUTICALS INC

CIK 0000729922

Entity typeother